Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Liquidia topped Wall Street’s second-quarter expectations Wednesday as sales of its lung disease treatment, Yutrepia, grew by double digits.
The post Liquidia, An IBD 50 Stock, Tops Sales Views Amid United Therapeutics Rivalry appeared first on Investor’s Business Daily.
